Key facts
- This page summarizes Robert P. Lenk's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Aug 2025, 07:30.
Robert P. Lenk - 22 Aug 2025 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)
- Reporting relationship
- Director
- Issuer ticker
- PSTV
- Reported as of
- 22 Aug 2025
- Net transaction value
- +$53,779
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2025, 07:30:05 UTC
- Prior SEC filing
- 15 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Sims, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert P. Lenk filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 25 Aug 2025.
Change
- Previous filing in this sequence was filed on 15 Aug 2025.
- Current net transaction value: +$53,779.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001362635
Primary reporting owner
Lenk Robert P
- Relationship
- Director
- Address
- C/O PLUS THERAPEUTICS INC., 4200 MARATHON BOULEVARD, SUITE 200, AUSTIN
- Signature
- /s/ Andrew Sims, attorney-in-fact
- Signature date
- 25 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PSTV
transaction
Common Stock
Purchase
- Transaction value
- $53,779
- Shares
- +110,000
- Change %
- +375%
- Price
- $0.4889
- Shares after
- 139,327
- Date
- 22 Aug 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.